|
US2735225A
(en)
|
|
1956-02-21 |
|
Table ix p petri dish tests with x-phthalimido- |
|
DE2253251A1
(de)
|
1972-10-30 |
1974-05-09 |
Thomae Gmbh Dr K |
Neue phthalimido-sulfonylharnstoffe
|
|
DE3474547D1
(en)
*
|
1983-12-02 |
1988-11-17 |
Shell Int Research |
Diphenyl ether herbicides
|
|
FR2659327A1
(fr)
|
1990-03-08 |
1991-09-13 |
Centre Nat Rech Scient |
Derives du benzisothiazolinone-1-dioxyde, utilisables comme inhibiteurs des elastases.
|
|
US5350761A
(en)
*
|
1991-07-30 |
1994-09-27 |
Ciba-Geigy Corporation |
Indolyl substituted hydroxylamine derivatives
|
|
US5334600A
(en)
*
|
1991-07-30 |
1994-08-02 |
Ciba-Geigy Corporation |
Isoquinolyl substituted hydroxylamine derivatives
|
|
DE69224115T2
(de)
|
1991-07-30 |
1998-08-20 |
Ciba Geigy Ag |
Heteroaryl substituierte Hydroxylaminderivate als Lipoxygenase-Inhibitoren
|
|
TW219935B
(enExample)
*
|
1991-12-25 |
1994-02-01 |
Mitsubishi Chemicals Co Ltd |
|
|
US5599811A
(en)
*
|
1995-02-21 |
1997-02-04 |
Warner-Lambert Company |
Benzothiazine dioxides as endothelin antagonists
|
|
PT891332E
(pt)
|
1996-03-29 |
2004-07-30 |
Pfizer |
Derivados de 6-fenilpiridil-2-amina
|
|
US6716836B2
(en)
*
|
2001-03-22 |
2004-04-06 |
Boehringer Ingelheim (Canada) Ltd. |
Non-nucleoside reverse transcriptase inhibitors
|
|
GB0124627D0
(en)
*
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
|
DE10348022A1
(de)
*
|
2003-10-15 |
2005-05-25 |
Imtm Gmbh |
Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
|
|
TW200613272A
(en)
*
|
2004-08-13 |
2006-05-01 |
Astrazeneca Ab |
Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
|
|
WO2006038594A1
(ja)
*
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
Ｎ型カルシウムチャネル阻害薬
|
|
US8110681B2
(en)
|
2006-03-17 |
2012-02-07 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Compounds for the treatment of spinal muscular atrophy and other uses
|
|
MY150746A
(en)
*
|
2006-12-27 |
2014-02-28 |
Sanofi Aventis |
Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase
|
|
JP5175866B2
(ja)
|
2007-02-22 |
2013-04-03 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Ｇタンパク質共役受容体を調節するための化合物および方法
|
|
KR101511396B1
(ko)
|
2007-07-20 |
2015-04-13 |
추가이 세이야쿠 가부시키가이샤 |
ｐ27 단백질 유도제
|
|
JP2012506386A
(ja)
*
|
2008-10-21 |
2012-03-15 |
メタボレックス， インコーポレイテッド |
アリールｇｐｒ１２０受容体アゴニストおよびその使用
|
|
AR074760A1
(es)
|
2008-12-18 |
2011-02-09 |
Metabolex Inc |
Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
|
|
CA2754688A1
(en)
*
|
2009-03-11 |
2010-09-16 |
Msd K.K. |
Novel isoindolin-1-one derivative
|
|
US8314120B2
(en)
*
|
2010-03-30 |
2012-11-20 |
Abbott Gmbh & Co. Kg |
Small molecule potentiators of metabotropic glutamate receptors
|
|
EP2582674B1
(en)
|
2010-06-16 |
2014-10-01 |
Cymabay Therapeutics, Inc. |
Gpr120 receptor agonists and uses thereof
|
|
US8299117B2
(en)
|
2010-06-16 |
2012-10-30 |
Metabolex Inc. |
GPR120 receptor agonists and uses thereof
|
|
TW201200505A
(en)
*
|
2010-06-17 |
2012-01-01 |
Metabolex Inc |
GPR120 receptor agonists and uses thereof
|
|
CA2841757A1
(en)
|
2011-07-15 |
2013-01-24 |
Etzer Darout |
Gpr 119 modulators
|
|
AR088989A1
(es)
|
2011-11-30 |
2014-07-23 |
Hoffmann La Roche |
Derivados biciclicos de dihidroisoquinolin-1-ona
|
|
CA2887348A1
(en)
|
2012-10-11 |
2014-04-17 |
Merck Sharp & Dohme Corp. |
Substituted spiropiperidinyl compounds useful as gpr120 agonists
|
|
KR101942752B1
(ko)
|
2012-11-05 |
2019-01-28 |
주식회사 엘지화학 |
Ｇｐｒ120 효능제로서의 티오아릴 유도체
|
|
RU2015123982A
(ru)
|
2012-12-03 |
2017-01-13 |
Ф. Хоффманн-Ля Рош Аг |
Соединения замещенных триазола и имидазола
|
|
US9714252B2
(en)
|
2012-12-20 |
2017-07-25 |
Purdue Pharma L.P. |
Cyclic sulfonamides as sodium channel blockers
|
|
CA2905729C
(en)
|
2013-03-14 |
2021-11-09 |
Janssen Pharmaceutica Nv |
Bicyclic pyrrole derivatives useful as agonists of gpr120
|
|
EP2970157B1
(en)
|
2013-03-14 |
2018-04-25 |
Janssen Pharmaceutica NV |
Benzo-fused heterocyclic derivatives useful as agonists of gpr120
|
|
ES2784489T3
(es)
|
2013-06-27 |
2020-09-28 |
Lg Chemical Ltd |
Derivados de biarilo como agonistas de GPR120
|
|
AR099937A1
(es)
|
2014-04-04 |
2016-08-31 |
Sanofi Sa |
Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados
|
|
AR100328A1
(es)
|
2014-05-07 |
2016-09-28 |
Bristol Myers Squibb Co |
Moduladores pirrolidina de gpr40
|
|
JP2017527559A
(ja)
|
2014-08-29 |
2017-09-21 |
シーエイチディーアイ ファウンデーション，インコーポレーテッド |
ハンチントンタンパク質のイメージング用プローブ
|
|
JP6486699B2
(ja)
|
2015-01-29 |
2019-03-20 |
国立大学法人金沢大学 |
脱水縮合剤
|
|
ES2989326T3
(es)
*
|
2015-10-21 |
2024-11-26 |
Otsuka Pharma Co Ltd |
Compuestos de benzolactama como inhibidores de la proteína cinasa
|
|
CN110225752B
(zh)
*
|
2016-09-12 |
2023-05-05 |
整体健康 |
用作gpr120调节器的单环化合物
|
|
US10865201B2
(en)
*
|
2016-09-12 |
2020-12-15 |
Valo Health, Inc. |
Bicyclic compounds useful as GPR120 modulators
|